New Zealand markets close in 1 hour 42 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
341.02-2.68 (-0.78%)
At close: 04:00PM EDT
341.02 0.00 (0.00%)
After hours: 05:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 9.53B
Enterprise value 9.31B
Trailing P/E N/A
Forward P/E 30.67
PEG ratio (5-yr expected) 1.19
Price/sales (ttm)3.85
Price/book (mrq)1.41
Enterprise value/revenue 3.63
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 3-6.58%
S&P500 52-week change 330.69%
52-week high 3366.30
52-week low 3261.59
50-day moving average 3328.73
200-day moving average 3313.25

Share statistics

Avg vol (3-month) 3314.12k
Avg vol (10-day) 3199.05k
Shares outstanding 522.79M
Implied shares outstanding 628.05M
Float 819.31M
% held by insiders 115.66%
% held by institutions 189.12%
Shares short (13 Sept 2024) 41.35M
Short ratio (13 Sept 2024) 46.3
Short % of float (13 Sept 2024) 47.82%
Short % of shares outstanding (13 Sept 2024) 44.83%
Shares short (prior month 15 Aug 2024) 4940k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 308 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin -51.73%
Operating margin (ttm)15.74%

Management effectiveness

Return on assets (ttm)2.11%
Return on equity (ttm)-17.41%

Income statement

Revenue (ttm)2.56B
Revenue per share (ttm)89.29
Quarterly revenue growth (yoy)-6.30%
Gross profit (ttm)N/A
EBITDA 514.17M
Net income avi to common (ttm)-1.33B
Diluted EPS (ttm)-47.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.62B
Total cash per share (mrq)57.99
Total debt (mrq)1.39B
Total debt/equity (mrq)20.54%
Current ratio (mrq)6.28
Book value per share (mrq)240.39

Cash flow statement

Operating cash flow (ttm)346.15M
Levered free cash flow (ttm)115.7M